Muzzey Dale 4
4 · MYRIAD GENETICS INC · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Muzzey Dale
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-03-24$9.98/sh−800$7,984→ 171,541 total - Tax Payment
Common Stock
2025-03-22$10.01/sh−2,011$20,130→ 178,220 total - Tax Payment
Common Stock
2025-03-22$10.01/sh−5,334$53,393→ 172,886 total - Tax Payment
Common Stock
2025-03-24$9.98/sh−545$5,439→ 172,341 total
Footnotes (4)
- [F1]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.
- [F2]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.
- [F3]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.
- [F4]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.